This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Journal of Biomedical Optics | |
|---|---|
| Title | Journal of Biomedical Optics |
| Discipline | Biomedical optics |
| Abbreviation | J. Biomed. Opt. |
| Publisher | SPIE |
| Country | United States |
| History | 1996–present |
| Frequency | Monthly |
| Openaccess | Hybrid |
| Issn | 1083-3668 |
Journal of Biomedical Optics is a peer-reviewed scientific periodical covering advances in biomedical photonics, imaging, and sensing that interface with engineering, medicine, and biology. The journal communicates original research, reviews, and technical notes that connect laboratory optics technologies to clinical applications, translational studies, and instrumentation development. It serves researchers, clinicians, and technologists across academic, industrial, and governmental institutions.
The journal was established in 1996 during a period of rapid growth in biomedical imaging driven by innovators associated with Stanford University, Massachusetts Institute of Technology, Johns Hopkins University, Harvard Medical School, and University of California, Irvine. Early editorial leadership included figures connected to SPIE and collaborative networks spanning National Institutes of Health, Wellcome Trust, European Research Council, and DARPA programs. The journal evolved alongside landmark projects at Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, Argonne National Laboratory, and consortia such as the Human Genome Project and the Human Connectome Project. Influential conferences like Photonics West, Optical Society of America (now Optica) meetings, BiOS, and workshops at Cold Spring Harbor Laboratory shaped its trajectory. Over time, editorial policies reflected trends from translational initiatives at Mayo Clinic, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, and regulatory dialogue with the United States Food and Drug Administration.
The journal publishes on topics spanning optical coherence tomography developments rooted in research from Massachusetts General Hospital, diffuse optical tomography informed by groups at University College London, fluorescence lifetime imaging techniques advanced at Imperial College London, and multiphoton microscopy methods common to labs at Rockefeller University and Max Planck Society institutes. Content often bridges device engineering from teams at Bell Labs and IBM Research with clinical trials at Stanford Hospital, translational research at University of California, San Francisco, and computational modeling from Princeton University and ETH Zurich. Articles relate to photonics methods relevant to Cancer Research UK, ophthalmology programs at Moorfields Eye Hospital, neuroscience partnerships with MIT McGovern Institute, and regenerative medicine centers at Karolinska Institutet. Instrumentation reports reference manufacturing partners such as Coherent, Inc., Thorlabs, and Zeiss; methodological articles cite collaborations with European Molecular Biology Laboratory and imaging archives like those at Broad Institute and Sanger Institute.
The journal is indexed in major bibliographic services connected to institutions such as PubMed and MEDLINE through associations with National Library of Medicine, citation databases from Clarivate Analytics (formerly Thomson Reuters) including Science Citation Index Expanded, and abstracting in Scopus overseen by Elsevier. Bibliometric tracking ties into datasets maintained by CrossRef, ORCID, Digital Science products, and national repositories coordinated with Library of Congress. Indexing facilitates discoverability for researchers at Yale University, Columbia University, University of Chicago, University of Toronto, and international centers like Peking University and Tsinghua University.
Editorial leadership historically includes editors connected to Duke University, University of Michigan, University of Pennsylvania, and University of Cambridge, with advisory board members from ETH Zurich, Karlsruhe Institute of Technology, University of Tokyo, Seoul National University, and National University of Singapore. Peer review practices align with standards promoted by organizations such as Committee on Publication Ethics and reflect policies analogous to those used by Nature Publishing Group, Science (journal), and The Lancet. Review workflows are managed using submission systems employed by scholarly societies including SPIE and integrate author identifier practices from ORCID and conflict-of-interest disclosures paralleling norms at World Health Organization-linked projects.
The journal produces research articles, review articles, technical notes, and special issues tied to symposia like Photonics West and thematic collections curated with partners such as National Science Foundation-funded programs. Publication formats accommodate high-resolution imagery, supplemental datasets archived with institutions like Dryad and Figshare, and video content similar to materials hosted by Journal of Visualized Experiments. Access models include subscription access distributed via SPIE Digital Library and hybrid open access options consistent with mandates from funders such as Wellcome Trust, European Commission Horizon 2020, NIH, and policies at Research Councils UK.
The journal’s impact metrics are tracked alongside journals in the domains of Optics Letters, Applied Optics, IEEE Transactions on Medical Imaging, Nature Photonics, and Nature Biomedical Engineering, with citation patterns observed at institutions like Imperial College London and Johns Hopkins University. It is cited in translational research from Memorial Sloan Kettering Cancer Center and multicenter studies coordinated with ClinicalTrials.gov registrations. Community reception reflects engagement from academic societies such as Optica (formerly OSA), IEEE Photonics Society, European Society for Biomedical Optics, and clinical organizations including American Academy of Ophthalmology.
Noteworthy contributions include early optical coherence tomography reports that influenced clinical ophthalmology at Moorfields Eye Hospital and cardiology studies linked to Cleveland Clinic Heart and Vascular Institute, fluorescence-guided surgery methodologies adopted at University College London Hospitals, label-free imaging approaches advanced at Max Planck Institute for Biophysical Chemistry, and diffuse optical spectroscopy applications used in neonatal care at Great Ormond Street Hospital. Papers have been foundational for technologies commercialized by companies such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and startups spun out from Stanford University and MIT. The journal’s archives inform policy discussions at National Institutes of Health and collaborative roadmaps developed with European Research Council panels.
Category:Biomedical journals Category:Optical engineering journals